June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Investigation of Suppressing the Recurrence Mechanism by Contact Lens Wearing for Gelatinous Drop-Like Corneal Degeneration
Author Affiliations & Notes
  • Toru Matsunaga
    Research and Development, SEED Co., Ltd., Kounosu-shi, Japan
    Ophthalmology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan
  • Yasuo Watanabe
    Research and Development, SEED Co., Ltd., Kounosu-shi, Japan
  • Toshinari Funaki
    Ophthalmology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan
  • Akira Murakami
    Ophthalmology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Japan
  • Footnotes
    Commercial Relationships Toru Matsunaga, JP5132958 (P), SEED Co., Ltd. (E); Yasuo Watanabe, SEED Co., Ltd. (E); Toshinari Funaki, None; Akira Murakami, JP4855782 (P), JP5132958 (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5659. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Toru Matsunaga, Yasuo Watanabe, Toshinari Funaki, Akira Murakami; Investigation of Suppressing the Recurrence Mechanism by Contact Lens Wearing for Gelatinous Drop-Like Corneal Degeneration. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5659.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Gelatinous drop-like corneal degeneration (GDLD) is a refractory disease that generates sub-epithelial deposition of amyloid. GDLD shows resistance to treatment with corneal transplantation and it is relapsed in a few years after surgery, but contact lens (CL) wearing has been reported to be effective for recurrent suppressed. We therefore evaluated for adhesion to CL of lactoferrin that is the main component of amyloid, to investigate the mechanism of recurrent suppressed with CL wearing.

Methods: Various soft contact lenses (SCL) were immersed into human lactoferrin solution (0.1mg / mL), and the adhesion of lactoferrin on SCL was quantified by ELISA after shaking at room temperature for 8 hours. Also, SCL obtained from GDLD patient was observed the adhesion of proteins by immunostaining using anti-lysozyme antibody and an anti-lactoferrin antibody. Also, tear fluid during SCL wearing and non-wearing condition were collected by capillary and each proteins quantified by ELISA.

Results: The adhesion amount of lactoferrin in each SCL was a small amount, but the SCL treated with lysozyme increased the adhesion amount. Also, the adhesion proteins in obtained SCL from GDLD patient were observed on whole surface of SCL, and many of adhesion of lactoferrin was observed in the surface of adhesion layer of lysozyme adhesion on the SCL surface. Furthermore, lysozyme and lactoferrin in tear fluid during SCL wearing condition showed low quantity compared with non-wearing condition.

Conclusions: SCL wearing after corneal transplant surgery in GDLD patients is supplemented the corneal epithelial barrier function and suppressed the loss of epithelium. Additionally, trapping a lactoferrin by SCL wearing is useful for suppressing the amyloid deposition and the recurrent.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×